Literature DB >> 12102253

Current trends in lung transplantation.

K C Stewart1, G A Patterson.   

Abstract

Lung transplantation provides very good short- and acceptable long-term survival for patients with advanced lung disease. More widespread use of marginal and distant donors can be employed in selected recipients without compromising early or late results. Lack of suitable donor lungs and the development of BOS represent the biggest obstacles to more widespread application and long-term success of lung transplantation. The high rate of acute rejection and subsequent BOS clearly indicates that current immunosuppression strategies are inadequate. Further clinical and laboratory research into the pathogenesis of BOS will perhaps reveal new treatment options.

Entities:  

Mesh:

Year:  2001        PMID: 12102253     DOI: 10.1034/j.1600-6143.2001.001003204.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  (3)He-MRI in follow-up of lung transplant recipients.

Authors:  Klaus Kurt Gast; Julia Zaporozhan; Sebastian Ley; Alexander Biedermann; Frank Knitz; Balthasar Eberle; Joerg Schmiedeskamp; Claus-Peter Heussel; Eckhard Mayer; Wolfgang Günter Schreiber; Manfred Thelen; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2003-10-16       Impact factor: 5.315

2.  Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection.

Authors:  Edward Seung; Josalyn L Cho; Tim Sparwasser; Benjamin D Medoff; Andrew D Luster
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

3.  Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Authors:  Xiang Xu; Jeffrey A Golden; Gregory Dolganov; Kirk D Jones; Samantha Donnelly; Timothy Weaver; George H Caughey
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

4.  De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Authors:  Trudie A Goers; Sabarinathan Ramachandran; Aviva Aloush; Elbert Trulock; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 5.  Bronchiolitis obliterans.

Authors:  Petey Laohaburanakit; Andrew Chan; Roblee P Allen
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

6.  BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.

Authors:  Benjamin D Medoff; Edward Seung; John C Wain; Terry K Means; Gabriele S V Campanella; Sabina A Islam; Seddon Y Thomas; Leo C Ginns; Nir Grabie; Andrew H Lichtman; Andrew M Tager; Andrew D Luster
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

7.  Trends and hospital outcomes of lung transplantation among patients with and without chronic obstructive pulmonary disease in Spain: a national population-based study (2001-2015).

Authors:  Javier de Miguel-Díez; Ana López-de-Andres; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Rodrigo Jiménez-García
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-03-27

8.  Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation.

Authors:  Shin Tanaka; Seiichiro Sugimoto; Takeshi Kurosaki; Kentaroh Miyoshi; Shinji Otani; Ken Suzawa; Shinsuke Hashida; Masaomi Yamane; Takahiro Oto; Shinichi Toyooka
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.